Sugar Maple Asset Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-30,800
Closed -$83.5K 89
2025
Q4
$83.5K Buy
+30,800
New +$101K 0.06% 83
2025
Q3
Sell
-38,000
Closed -$189K 83
2025
Q2
$189K Buy
+38,000
New +$165K 0.15% 70
2025
Q1
Sell
-26,250
Closed -$122K 215
2024
Q4
$122K Buy
+26,250
New +$144K 0.09% 82

Other funds holding GDRX

Sugar Maple Asset Management's GDRX Position: Q1 2026 in Review

Sugar Maple Asset Management sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 30,800 shares — an estimated $83.5K sold.

Sugar Maple Asset Management first reported a position in GDRX in Q4 2024 and held it in 3 quarters. The position peaked at $189K in Q2 2025. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Sugar Maple Asset Management reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
  • Sugar Maple Asset Management sold 30,800 GoodRx Holdings shares in Q1 2026, an estimated $83.5K.
  • Sugar Maple Asset Management first reported a position in GoodRx Holdings in Q4 2024 and held it in 3 quarters.
  • Sugar Maple Asset Management's GoodRx Holdings position peaked at $189K in Q2 2025.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Sugar Maple Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.